Jacek Lesinski: The Importance of Whole Blood and Plasma Donation
Jacek Lesinski, a 3rd-year medical laboratory technology apprentice at Rheinisches Bildungszentrum Köln in Germany, specializing in morphological hematology and microscopy, shared a post on LinkedIn:
“Blood Donations
When people think about blood donation, they usually picture the classic whole blood donation. But there is also plasma donation – both are essential and make a big difference in patient care.
Whole Blood Donation
• Processed into:
• Red cell concentrates (RBCs) – for patients with blood loss or anemia
• Platelet concentrates – for patients with bleeding disorders or after chemotherapy
• Plasma – e.g. for clotting disorders
Plasma Donation
• Plasma is used in pharmaceutical manufacturing, for example to produce:
• Immunoglobulins (for people with immune deficiencies)
• Albumin (for burn victims or shock patients)
• Coagulation factors (for patients with hemophilia)
Additional Benefits for Donors
• Regular health checks (blood pressure, hemoglobin, infectious disease screening)
• Financial compensation for plasma donations (depending on the country)
• A sense of wellbeing: studies show regular donation can stimulate new blood cell production
To summarize: these donations are of high importance to us, to lab staff, doctors and patients. And still many people do not donate blood, of course there can be several reasons to abstain however many people just forget this topic.
Every healthy person should donate blood!”
Stay informed with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis